Income Statement

GLOBUS MEDICAL INC

GMED
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY
Revenue
2,938.93 2,519.36 1,568.48 1,022.84 958.10 789.04 785.37 712.97 635.98 563.99 544.75 474.37 434.46 385.99
Cost of Revenue
957.80 1,035.48 548.17 263.73 239.22 217.46 179.98 159.41 - - - - - -
Gross Profit
1,981.13 1,483.88 1,020.30 759.12 718.88 571.58 605.39 553.56 485.52 429.29 411.95 363.51 334.12 310.80
Operating Expenses
1,325.74 1,144.80 887.16 531.17 546.93 460.15 433.40 384.23 323.68 275.15 239.73 225.15 232.44 196.00
Research & Development
147.25 163.75 124.01 73.02 97.35 84.52 60.07 55.50 43.68 44.53 36.98 31.69 26.87 27.93
Selling, General & Administrative
1,178.50 981.05 643.41 432.12 408.15 354.76 354.76 311.59 267.82 222.16 214.01 187.80 182.52 168.86
Other Operating Expenses
- - - - - - - - - - - - - -
Operating Income
655.39 339.07 133.14 227.95 171.95 111.43 171.99 169.33 161.84 154.14 172.22 138.36 101.67 114.79
Non-Operating Income
125.25 -45.27 -32.25 -15.07 -8.45 -14.47 -17.96 -19.28 -8.09 -3.14 -0.58 -0.28 -0.33 0.14
Interest Income
- - - - - - - - - - - - - -
Interest Expense
6.94 28.32 9.44 - - - - - - - - - - -
Other Non-Op Income / Expense
3.41 2.21 32.25 15.07 8.45 14.47 17.96 19.28 8.09 3.14 0.58 0.28 0.33 -0.14
Income Before Tax
605.07 120.72 165.39 243.02 180.41 125.90 189.95 188.61 169.93 157.28 172.81 138.64 102.00 114.65
Income Tax Expense
67.20 17.74 42.52 52.85 31.22 23.61 34.74 32.13 62.58 52.94 60.02 46.16 33.39 40.82
Non-Controlling Interest
- - - - - - - - - - - - - -
Net Income
537.87 102.98 122.87 190.17 149.19 102.29 155.21 156.47 107.35 104.34 112.78 92.49 68.61 73.83
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY
Depreciation & Amortization
- - - - - - - - - - - - - -
EBITDA
932.23 593.10 277.88 296.20 241.82 174.31 224.72 210.96 203.91 192.91 196.31 160.12 121.07 132.90
Earnings Per Share (Basic)
3.98 0.76 1.09 1.89 1.48 1.04 1.57 1.60 1.12 1.09 1.19 0.98 0.74 0.82
Diluted EPS
3.92 0.75 1.07 1.85 1.44 1.01 1.52 1.54 1.10 1.08 1.17 0.97 0.73 0.80
Weighted Average Shares
135.22 135.73 113.09 100.47 100.73 98.58 99.15 97.88 96.24 95.65 95.05 94.23 92.65 89.61
Diluted Weighted Avg Shares
137.06 137.86 114.63 102.64 103.62 100.97 102.00 101.32 97.89 96.43 96.07 95.46 94.19 92.21
Comprehensive Income
560.08 106.32 137.31 172.31 138.46 109.14 159.48 156.47 109.08 104.34 112.78 92.49 68.61 74.27